Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 26, 2016 - Issue 2
Submit an article Journal homepage
571
Views
28
CrossRef citations to date
0
Altmetric
Reviews

Lessons from black pepper: piperine and derivatives thereof

D. ChavarriaCIQUP/Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto, Portugal
,
T. SilvaCIQUP/Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto, Portugal
,
D. Magalhães e SilvaCIQUP/Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto, Portugal
,
F. RemiãoUCIBIO-REQUIMTE, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal
&
F. BorgesCIQUP/Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto, PortugalCorrespondence[email protected]
Pages 245-264 | Received 10 Jun 2015, Accepted 05 Nov 2015, Published online: 05 Dec 2015

Bibliography

  • Papers of special note have been highlighted as either of interest (•) or of considerable interest (••) to readers.
  • Butt MS, Pasha I, Sultan MT, et al. Black pepper and health claims: a comprehensive treatise. Crit Rev Food Sci Nutr. 2013;53:875–886.

•• Review of chemical and biological background

  • Koleva II, Van Beek TA, Soffers AEMF, et al. Alkaloids in the human food chain - natural occurrence and possible adverse effects. Mol Nutr Food Res. 2012;56:30–52.
  • Bunsupa S, Yamazaki M, Saito K. Quinolizidine alkaloid biosynthesis: recent advances and future prospects. Front Plant Sci. 2012;3:1–7.
  • Srinivasan K. Black pepper and its pungent principle-piperine: a review of diverse physiological effects. Crit Rev Food Sci Nutr. 2007;47:735–748.

•• Review of chemical and biological background

  • Alugolu V, Rentala S, Komarraju AL, et al. Docking studies of piperine - iron conjugate with human CYP450 3A4. Bioinformation. 2013;9:334–338.
  • Bhardwaj RK, Glaeser H, Becquemont L, et al. Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. J Pharmacol Exp Ther. 2002;302:645–650.

• Influence of piperine on drug metabolism and efflux regulators

  • Johnson JJ, Nihal M, Siddiqui IA, et al. Enhancing the bioavailability of resveratrol by combining it with piperine. Mol Nutr Food Res. 2012;55:1169–1176.
  • Bishnoi M, Chopra K, Rongzhu L, et al. Protective effect of curcumin and its combination with piperine (bioavailability enhancer) against haloperidol-associated neurotoxicity: cellular and neurochemical evidence. Neurotox Res. 2011;20:215–225.
  • Rinwa P, Kumar A. Quercetin along with piperine prevents cognitive dysfunction, oxidative stress and neuro-inflammation associated with mouse model of chronic unpredictable stress. Arch Pharm Res. 2013;1–10. DOI:10.1007/s12272-013-0205-4.
  • Verkantesh S, Durga K, Padmavathi Y, et al. Influence of piperine on ibuprofen induced antinociception and its pharmacokinetics. Arzneimittelforschung. 2011;61:506–509.
  • Gupta SK, Bansal P, Bhardwaj RK, et al. Comparative anti-nociceptive, anti-inflammatory and toxicity profile of nimesulide vs nimesulide and piperine combination. Pharmacol Res. 2000;41:657–662.
  • Sama V, Nadipelli M, Yenumula P, et al. Effect of piperine on antihyperglycemic activity and pharmacokinetic profile of nateglinide. Arzneimittelforschung. 2012;62:384–388.
  • Veeresham C, Sujatha S, Rani T. Effect of piperine on the pharmacokinetics and pharmacodynamics of glimepiride in normal and streptozotocin-induced diabetic rats. Nat Prod Commun. 2012;7:1283–1286.
  • Jin MJ, Han HK. Effect of piperine, a major component of black pepper, on the intestinal absorption of fexofenadine and its implication on food-drug interaction. J Food Sci. 2010;75:H93–H96.
  • Velpandian T, Jasuja R, Bhardwaj RK, et al. Piperine in food: interference in the pharmacokinetics of phenytoin. Eur J Drug Metab Pharmacokinet. 2001;26:241–247.
  • Pattanaik S, Hota D, Prabhakar S, et al. Effect of piperine on the steady-state pharmacokinetics of phenytoin in patients with epilepsy. Phyther Res. 2006;20:683–686.
  • Kashibhata R, Naidu M. Influence of piperine on the pharmacokinetics of nevirapine under fasting conditions: a randomised, crossover, placebo-controlled study. Drugs R D. 2007;8:383–391.
  • Han H-K. The effects of black pepper on the intestinal absorption and hepatic metabolism of drugs. Expert Opin Drug Metab Toxicol. 2011;7:721–729.
  • Tharmalingam N, Kim S, Park M, et al. Inhibitory effect of piperine on Helicobacter pylori growth and adhesion to gastric adenocarcinoma cells. Infect Agent Cancer. 2014;9:1–10.
  • Zhang J, Zhu X, Li H, et al. Piperine inhibits proliferation of human osteosarcoma cells via G2/M phase arrest and metastasis by suppressing MMP-2/-9 expression. Int Immunopharmacol. 2015;24:50–58.
  • Yaffe PB, Power Coombs MR, Doucette CD, et al. Piperine, an alkaloid from black pepper, inhibits growth of human colon cancer cells via G1 arrest and apoptosis triggered by endoplasmic reticulum stress. Mol Carcinog. 2014;54:1070–1085.
  • Greenshields AL, Doucette CD, Sutton KM, et al. Piperine inhibits the growth and motility of triple-negative breast cancer cells. Cancer Lett. 2015;357:129–140.
  • Xia Y, Khoi PN, Yoon HJ, et al. Piperine inhibits IL-1β-induced IL-6 expression by suppressing p38 MAPK and STAT3 activation in gastric cancer cells. Mol Cell Biochem. 2014;398:147–156.
  • Lai L, Fu Q, Liu Y, et al. Piperine suppresses tumor growth and metastasis in vitro and in vivo in a 4T1 murine breast cancer model. Acta Pharmacol Sin. 2012;33:523–530.
  • Fofaria NM, Kim SH, Srivastava SK. Piperine causes G1 phase cell cycle arrest and apoptosis in melanoma cells through checkpoint kinase-1 activation. PLoS One. 2014;9:1–10.
  • Hou X-F, Pan H, Xu L-H, et al. Piperine suppresses the expression of CXCL8 in lipopolysaccharide-activated SW480 and HT-29 cells via downregulating the mitogen-activated protein kinase pathways. Inflammation. 2014;38:1093–1102.
  • Gupta RA, Motiwala MN, Dumore NG, et al. Effect of piperine on inhibition of FFA induced TLR4 mediated inflammation and amelioration of acetic acid induced ulcerative colitis in mice. J Ethnopharmacol. 2015;164:239–246.
  • Dong Y, Huihui Z, Li C. Piperine inhibit inflammation, alveolar bone loss and collagen fibers breakdown in a rat periodontitis model. J Periodontal Res. 2015;1–8. DOI:10.1111/jre.12262.
  • Bojjireddy N, Sinha RK, Subrahmanyam G. Piperine inhibits type II phosphatidylinositol 4-kinases: a key component in phosphoinositides turnover. Mol Cell Biochem. 2014;393:9–15.
  • Ying X, Yu K, Chen X, et al. Piperine inhibits LPS induced expression of inflammatory mediators in RAW 264.7 cells. Cell Immunol. 2013;285:49–54.
  • Umar S, Golam Sarwar AHM, Umar K, et al. Piperine ameliorates oxidative stress, inflammation and histological outcome in collagen induced arthritis. Cell Immunol. 2013;284:51–59.
  • Ying X, Chen X, Cheng S, et al. Piperine inhibits IL-β induced expression of inflammatory mediators in human osteoarthritis chondrocyte. Int Immunopharmacol. 2013;17:293–299.
  • Jiang ZY, Liu WF, Zhang XM, et al. Anti-HBV active constituents from Piper longum. Bioorganic Med Chem Lett. 2013;23:2123–2127.
  • Kumar A, Raman RP, Kumar K, et al. Antiparasitic efficacy of piperine against Argulus spp. on Carassius auratus (Linn. 1758): in vitro and in vivo study. Parasitol Res. 2012;111:2071–2076.
  • Sharma S, Kalia NP, Suden P, et al. Protective efficacy of piperine against Mycobacterium tuberculosis. Tuberculosis. 2014;94:389–396.
  • Ferreira C, Soares DC, Barreto-Junior CB, et al. Leishmanicidal effects of piperine, its derivatives, and analogues on Leishmania amazonensis. Phytochemistry. 2011;72:2155–2164.
  • Freire-De-Lima L, Ribeiro TS, Rocha GM, et al. The toxic effects of piperine against Trypanosoma cruzi: ultrastructural alterations and reversible blockage of cytokinesis in epimastigote forms. Parasitol Res. 2008;102:1059–1067.
  • Mohtar M, Johari SA, Li AR, et al. Inhibitory and resistance-modifying potential of plant-based alkaloids against methicillin-resistant Staphylococcus aureus (MRSA). Curr Microbiol. 2009;59:181–186.
  • Meghwal M, Goswami TK. Piper nigrum and piperine: an update. Phyther Res. 2013;27:1121–1130.
  • Brincat JP, Broccatelli F, Sabatini S, et al. Ligand promiscuity between the efflux pumps human p-glycoprotein and S. aureus NorA. ACS Med Chem Lett. 2012;3:248–251.
  • Cuestas ML, Castillo AI, Sosnik A, et al. Downregulation of mdr1 and abcg2 genes is a mechanism of inhibition of efflux pumps mediated by polymeric amphiphiles. Bioorganic Med Chem Lett. 2012;22:6577–6579.
  • Sun J, Deng Z, Yan A. Bacterial multidrug efflux pumps: mechanisms, physiology and pharmacological exploitations. Biochem Biophys Res Commun. 2014;453:254–267.
  • Ramalhete C, Spengler G, Martins A, et al. Inhibition of efflux pumps in meticillin-resistant Staphylococcus aureus and Enterococcus faecalis resistant strains by triterpenoids from Momordica balsamina. Int J Antimicrob Agents. 2011;37:70–74.
  • Kumar A, Khan IA, Koul S, et al. Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus. J Antimicrob Chemother. 2008;61:1270–1276.
  • Amin L. P-glycoprotein inhibition for optimal drug delivery. Drug Target Insights. 2013;7:27–34.
  • DeGorter MK, Xia CQ, Yang JJ, et al. Drug transporters in drug efficacy and toxicity. Annu Rev Pharmacol Toxicol. 2012;52:249–273.
  • Koul S, Koul J, Taneja S, et al. Aromatic amides as potentiators of bioefficacy of anti-infective drugs. US 20070004645 A1. 2007.

• Patent with multiple strategies to obtain piperine derivatives modified on the alkene spacer and the amide moiety

  • Wiegand I, Hilpert K, Hancock REW. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc. 2008;3:163–175.
  • Sangwan PL, Koul JL, Koul S, et al. Piperine analogs as potent Staphylococcus aureus NorA efflux pump inhibitors. Bioorganic Med Chem. 2008;16:9847–9857.
  • Sachin BS, Najar IA, Sharma SC, et al. Simultaneous determination of etoposide and a piperine analogue (PA-1) by UPLC-qTOF-MS: evidence that PA-1 enhances the oral bioavailability of etoposide in mice. J Chromatogr B. 2010;878:823–830.
  • Najar IA, Sharma SC, Singh GD, et al. Involvement of P-glycoprotein and CYP 3A4 in the enhancement of etoposide bioavailability by a piperine analogue. Chem Biol Interact. 2011;190:84–90.
  • Evangelopoulos D, Diniz J, Waddell SJ. Understanding anti-tuberculosis drug efficacy : rethinking bacterial populations and how we model them. Int J Infect Dis. 2015;32:76–80.
  • Pham -D-D, Fattal E, Tsapis N. Pulmonary drug delivery systems for the treatment of tuberculosis. Int J Pharm. 2015;478:517–529.
  • Sharma S, Kumar M, Sharma S, et al. Piperine as an inhibitor of Rv1258c, a putative multidrug efflux pump of Mycobacterium tuberculosis. J Antimicrob Chemother. 2010;65:1694–1701.
  • Zhou A, Ni J, Xu Z, et al. Application of 1H NMR spectroscopy-based metabolomics to sera of tuberculosis patients. J Proteome Res. 2013;12:4642–4649.
  • Naik M, Ghorpade S, Jena LK, et al. 2-Phenylindole and arylsulphonamide: novel scaffolds bactericidal against Mycobacterium tuberculosis. ACS Med Chem Lett. 2014;5:1005–1009.
  • Reddi DS, Ramesh R. Antitubercular compounds and process for the preparation thereof. WO2014128724 A1. 2014.
  • Menna-Barreto RFS, Salomão K, Dantas AP, et al. Different cell death pathways induced by drugs in Trypanosoma cruzi: an ultrastructural study. Micron. 2009;40:157–168.
  • Osorio L, Ríos I, Gutiérrez B, et al. Virulence factors of Trypanosoma cruzi: who is who? Microbes Infect. 2012;14:1390–1402.
  • da Silva Ferreira W, Freire-de-Lima L, Saraiva VB, et al. Novel 1,3,4-thiadiazolium-2-phenylamine chlorides derived from natural piperine as trypanocidal agents: chemical and biological studies. Bioorganic Med Chem. 2008;16:2984–2991.
  • Aponte JC, Verástegui M, Málaga E, et al. Synthesis, cytotoxicity, and anti-Trypanosoma cruzi activity of new chalcones. J Med Chem. 2008;51:6230–6234.
  • Da Silva EF, Canto-Cavalheiro MM, Braz VR, et al. Synthesis, and biological evaluation of new 1,3,4-thiadiazolium-2-phenylamine derivatives against Leishmania amazonensis promastigotes and amastigotes. Eur J Med Chem. 2002;37:979–984.
  • Leprohon P, Fernandez-Prada C, Gazanion É, et al. Drug resistance analysis by next generation sequencing in Leishmania. Int J Parasitol Drugs Drug Resist. 2015;5:26–35.
  • Hutton JA, Goncalves V, Brannigan JA, et al. Structure-based design of potent and selective leishmania N−myristoyltransferase inhibitors. J Med Chem. 2014;57:8664−8670.
  • Syrjänen L, Vermelho AB, De Almeida Rodrigues I, et al. Cloning, characterization, and inhibition studies of a β-carbonic anhydrase from Leishmania donovani chagasi, the protozoan parasite responsible for leishmaniasis. J Med Chem. 2013;56:7372–7381.
  • Yadav A, Amit A, Chaudhary R, et al. Leishmania donovani: impairment of the cellular immune response against recombinant ornithine decarboxylase protein as a possible evasion strategy of Leishmania in visceral leishmaniasis. Int J Parasitol. 2015;45:33–42.
  • Singh IP, Jain SK, Kaur A, et al. Synthesis and antileishmanial activity of piperoyl-amino acid conjugates. Eur J Med Chem. 2010;45:3439–3445.
  • Gavva NR, Bannon AW, Surapaneni S, et al. The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation. J Neurosci. 2007;27:3366–3374.
  • Peng J, Li YJ. The vanilloid receptor TRPV1: role in cardiovascular and gastrointestinal protection. Eur J Pharmacol. 2010;627:1–7.
  • Szallasi A, Cortright DN, Blum CA, et al. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nat Rev Drug Discov. 2007;6:357–372.
  • Khairatkar-Joshi N, Szallasi A. TRPV1 antagonists: the challenges for therapeutic targeting. Trends Mol Med. 2009;15:14–22.
  • McNamara FN, Randall A, Gunthorpe MJ. Effects of piperine, the pungent component of black pepper, at the human vanilloid receptor (TRPV1). Br J Pharmacol. 2005;144:781–790.
  • Saku O, Ishida H, Atsumi E, et al. Discovery of novel 5,5-diarylpentadienamides as orally available transient receptor potential vanilloid 1 (TRPV1) antagonists. J Med Chem. 2012;55:3436–3451.
  • Charych EI, Liu F, Moss SJ, et al. GABAA receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders. Neuropharmacology. 2009;57:481–495.
  • Zaugg J, Baburin I, Strommer B, et al. HPLC-based activity profiling: discovery of piperine as a positive GABAA receptor modulator targeting a benzodiazepine-independent binding site. J Nat Prod. 2010;73:185–191.
  • Wimmer L, Schönbauer D, Pakfeifer P, et al. Developing piperine towards TRPV1 and GABAA via Heck-coupling of conjugated dienes. Org Biomol Chem. 2015;13:990–994.
  • Khom S, Strommer B, Schöffmann A, et al. GABAA receptor modulation by piperine and a non-TRPV1 activating derivative. Biochem Pharmacol. 2013;85:1827–1836.
  • Hering S, Erker T, Schwarz T, et al. Novel piperine derivatives as GABAA receptors modulators, WO2011080313 A1. 2011.
  • Schöffmann A, Wimmer L, Goldmann D, et al. Efficient modulation of γ-aminobutyric acid type a receptors by piperine derivatives. J Med Chem. 2014;57:5602–5619.

• Original article with diverse strategies to integrate aryl cores on the alkene spacer of piperine derivatives

  • Legoabe L, Kruger J, Petzer A, et al. Monoamine oxidase inhibition by selected anilide derivatives. Eur J Med Chem. 2011;46:5162–5174.
  • Mu LH, Wang B, Ren HY, et al. Synthesis and inhibitory effect of piperine derivates on monoamine oxidase. Bioorganic Med Chem Lett. 2012;22:3343–3348.
  • Kong LD, Cheng CHK, Tan RX. Inhibition of MAO A and B by some plant-derived alkaloids, phenols and anthraquinones. J Ethnopharmacol. 2004;91:351–355.
  • Lee SA, Hong SS, Han XH, et al. Piperine from the fruits of Piper longum with inhibitory effect on monoamine oxidase and antidepressant-like activity. Chem Pharm Bull (Tokyo). 2005;53:832–835.
  • Petzer JP, Castagnoli N, Schwarzschild MA, et al. Dual-target – directed drugs that block monoamine oxidase B and adenosine A2A receptors for Parkinson’s disease. Neurotherapeutics. 2009;6:141–151.
  • Jenner P, Mori A, Hauser R, et al. Adenosine, adenosine A2A antagonists, and Parkinson’s disease. Park Relat Disord. 2009;15:406–413.
  • Pretorius J, Malan SF, Castagnoli N, et al. Dual inhibition of monoamine oxidase B and antagonism of the adenosine A2A receptor by (E,E)-8-(4-phenylbutadien-1-yl)caffeine analogues. Bioorganic Med Chem. 2008;16:8676–8684.
  • Stößel A, Schlenk M, Hinz S, et al. Dual targeting of adenosine A2A receptors and monoamine oxidase B by 4H-3,1-benzothiazin-4-ones. J Med Chem. 2013;56:4580–4596.
  • Jain R, Singh A. Pharmaceutical compositions containing NSAIDs and piperine. EP 0935964 A1. 1999.
  • Bhatt DD, Trivedi MR, Modi IA, et al. Pharmaceutical composition of isoniazid. WO 2011012987 A1. 2011.
  • Bedi KL, Dhar SK, Johri RK, et al. Pharmaceutical compositions containing piperine and an antituberculosis or antileprosydrug. EP 0650728 B1. 2002.
  • Di PF. Compositions containing a phospholipid-curcumin complex and piperine as chemosensitizing agent, EP 2228062 A1. 2010.
  • Shrivastava P, Vaibhav K, Tabassum R, et al. Anti-apoptotic and anti-inflammatory effect of piperine on 6-OHDA induced Parkinson’s Rat model. J Nutr Biochem. 2013;24:680–687.
  • Chonpathompikunlert P, Wattanathorn J, Muchimapura S. Piperine, the main alkaloid of Thai black pepper, protects against neurodegeneration and cognitive impairment in animal model of cognitive deficit like condition of Alzheimer’s disease. Food Chem Toxicol. 2010;48:798–802.
  • Mao QQ, Huang Z, Ip SP, et al. Protective effects of piperine against corticosterone-induced neurotoxicity in PC12 cells. Cell Mol Neurobiol. 2012;32:531–537.
  • Mao QQ, Huang Z, Zhong XM, et al. Piperine reverses the effects of corticosterone on behavior and hippocampal BDNF expression in mice. Neurochem Int. 2014;74:36–41.
  • Al-Baghdadi OB, Prater NI, Van Der Schyf CJ, et al. Inhibition of monoamine oxidase by derivatives of piperine, an alkaloid from the pepper plant Piper nigrum, for possible use in Parkinson’s disease. Bioorganic Med Chem Lett. 2012;22:7183–7188.
  • Koeberle A, Werz O. Multi-target approach for natural products in inflammation. Drug Discov Today. 2014;19:1871–1882.
  • Kozukue N, Park MS, Choi SH, et al. Kinetics of light-induced cis-trans isomerization of four piperines and their levels in ground black peppers as determined by HPLC and LC/MS. J Agric Food Chem. 2007;55:7131–7139.
  • Kakarala M, Dubey SK, Tarnowski M, et al. Ultra-low flow liquid chromatography assay with ultraviolet (UV) detection for piperine quantitation in human plasma. J Agric Food Chem. 2010;58:6594–6599.
  • Ternes W, Krause EL. Characterization and determination of piperine and piperine isomers in eggs. Anal Bioanal Chem. 2002;374:155–160.
  • Soumyanath A, Venkatasamy R, Joshi M, et al. UV irradiation affects melanocyte stimulatory activity and protein binding of piperine. Photochem Photobiol. 2006;82:1541–1548.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.